Biology of Tenascin C and Its Role in Physiology and Pathology

Overview

Journal Curr Med Chem

Publisher Bentham Science Publishers

Specialty Chemistry

Date 2023 Apr 6

PMID 37021423

Authors

Malihehsadat Abedsaeidi

Farzaneh Hojjati

Amin Tavassoli

Amirhossein Sahebkar

Affiliations

Soon will be listed here.

Abstract

Tenascin-C (TNC) is a multimodular extracellular matrix (ECM) protein hexameric with several molecular forms (180-250 kDa) produced by alternative splicing at the pre-mRNA level and protein modifications. The molecular phylogeny indicates that the amino acid sequence of TNC is a well-conserved protein among vertebrates. TNC has binding partners, including fibronectin, collagen, fibrillin-2, periostin, proteoglycans, and pathogens. Various transcription factors and intracellular regulators tightly regulate TNC expression. TNC plays an essential role in cell proliferation and migration. Unlike embryonic tissues, TNC protein is distributed over a few tissues in adults. However, higher TNC expression is observed in inflammation, wound healing, cancer, and other pathological conditions. It is widely expressed in a variety of human malignancies and is recognized as a pivotal factor in cancer progression and metastasis. Moreover, TNC increases both pro-and anti-inflammatory signaling pathways. It has been identified as an essential factor in tissue injuries such as damaged skeletal muscle, heart disease, and kidney fibrosis. This multimodular hexameric glycoprotein modulates both innate and adaptive immune responses regulating the expression of numerous cytokines. Moreover, TNC is an important regulatory molecule that affects the onset and progression of neuronal disorders through many signaling pathways. We provide a comprehensive overview of the structural and expression properties of TNC and its potential functions in physiological and pathological conditions.

Citing Articles

Tenascin-C from the tissue microenvironment promotes muscle stem cell self-renewal through Annexin A2.

Loreti M, Cecchini A, Kaufman C, Stamenkovic C, Renero A, Nicoletti C bioRxiv. 2024; .

PMID: 39554125 PMC: 11565721. DOI: 10.1101/2024.10.29.620732.

Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies.

Pomella S, Melaiu O, Cifaldi L, Bei R, Gargari M, Campanella V Int J Mol Sci. 2024; 25(16).

PMID: 39201614 PMC: 11354375. DOI: 10.3390/ijms25168929.

Extracellular Matrix Structure and Interaction with Immune Cells in Adult Astrocytic Tumors.

Di Vito A, Donato A, Bria J, Conforti F, La Torre D, Malara N Cell Mol Neurobiol. 2024; 44(1):54.

PMID: 38969910 PMC: 11226480. DOI: 10.1007/s10571-024-01488-z.

Thoughts on the Etiology of Cherubism.

Hyckel P, Liehr T J Clin Med. 2024; 13(7).

PMID: 38610846 PMC: 11012468. DOI: 10.3390/jcm13072082.

Mechanistic role of quercetin as inhibitor for adenosine deaminase enzyme in rheumatoid arthritis: systematic review.

Atta A, Salem M, El-Said K, Mohamed T Cell Mol Biol Lett. 2024; 29(1):14.

PMID: 38225555 PMC: 10790468. DOI: 10.1186/s11658-024-00531-7.

References

Giblin S, Midwood K . Tenascin-C: Form versus function. Cell Adh Migr. 2014; 9(1-2):48-82. PMC: 4422809. DOI: 10.4161/19336918.2014.987587. View

Lowy C, Oskarsson T . Tenascin C in metastasis: A view from the invasive front. Cell Adh Migr. 2015; 9(1-2):112-24. PMC: 4422797. DOI: 10.1080/19336918.2015.1008331. View

Midwood K, Chiquet M, Tucker R, Orend G . Tenascin-C at a glance. J Cell Sci. 2016; 129(23):4321-4327. DOI: 10.1242/jcs.190546. View

Midwood K, Orend G . The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal. 2009; 3(3-4):287-310. PMC: 2778592. DOI: 10.1007/s12079-009-0075-1. View

Chiquet M, Fambrough D . Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol. 1984; 98(6):1926-36. PMC: 2113040. DOI: 10.1083/jcb.98.6.1926. View

Chiquet-Ehrismann R, Matsuoka Y, Hofer U, Spring J, Bernasconi C, Chiquet M . Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul. 1991; 2(11):927-38. PMC: 361891. DOI: 10.1091/mbc.2.11.927. View

Zuliani-Alvarez L, Marzeda A, Deligne C, Schwenzer A, McCann F, Marsden B . Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers. Nat Commun. 2017; 8(1):1595. PMC: 5693923. DOI: 10.1038/s41467-017-01718-7. View

Yokosaki Y, Monis H, Chen J, Sheppard D . Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains. J Biol Chem. 1996; 271(39):24144-50. DOI: 10.1074/jbc.271.39.24144. View

Midwood K, Sacre S, Piccinini A, Inglis J, Trebaul A, Chan E . Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009; 15(7):774-80. DOI: 10.1038/nm.1987. View

10.

Nikoloudaki G . Functions of Matricellular Proteins in Dental Tissues and Their Emerging Roles in Orofacial Tissue Development, Maintenance, and Disease. Int J Mol Sci. 2021; 22(12). PMC: 8235165. DOI: 10.3390/ijms22126626. View

11.

Okada T, Suzuki H . The Role of Tenascin-C in Tissue Injury and Repair After Stroke. Front Immunol. 2021; 11:607587. PMC: 7859104. DOI: 10.3389/fimmu.2020.607587. View

12.

Fujimoto N, Onishi K, Sato A, Terasaki F, Tsukada B, Nozato T . Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure. J Card Fail. 2009; 15(10):898-905. DOI: 10.1016/j.cardfail.2009.06.443. View

13.

Bourdon M, Wikstrand C, Furthmayr H, Matthews T, Bigner D . Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res. 1983; 43(6):2796-805. View

14.

Erickson H, Inglesias J . A six-armed oligomer isolated from cell surface fibronectin preparations. Nature. 1984; 311(5983):267-9. DOI: 10.1038/311267a0. View

15.

Kruse J, Keilhauer G, Faissner A, Timpl R, Schachner M . The J1 glycoprotein--a novel nervous system cell adhesion molecule of the L2/HNK-1 family. Nature. 1985; 316(6024):146-8. DOI: 10.1038/316146a0. View

16.

Grumet M, Hoffman S, Chuong C, Edelman G . Polypeptide components and binding functions of neuron-glia cell adhesion molecules. Proc Natl Acad Sci U S A. 1984; 81(24):7989-93. PMC: 392279. DOI: 10.1073/pnas.81.24.7989. View

17.

Erickson H, Taylor H . Hexabrachion proteins in embryonic chicken tissues and human tumors. J Cell Biol. 1987; 105(3):1387-94. PMC: 2114792. DOI: 10.1083/jcb.105.3.1387. View

18.

Chiquet-Ehrismann R, Mackie E, Pearson C, Sakakura T . Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell. 1986; 47(1):131-9. DOI: 10.1016/0092-8674(86)90374-0. View

19.

Tucker R, Chiquet-Ehrismann R . Evidence for the evolution of tenascin and fibronectin early in the chordate lineage. Int J Biochem Cell Biol. 2008; 41(2):424-34. DOI: 10.1016/j.biocel.2008.08.003. View

20.

Adams J, Chiquet-Ehrismann R, Tucker R . The evolution of tenascins and fibronectin. Cell Adh Migr. 2014; 9(1-2):22-33. PMC: 4422808. DOI: 10.4161/19336918.2014.970030. View